Carbodenafil

CAS No. 944241-52-5

Carbodenafil( —— )

Catalog No. M26086 CAS No. 944241-52-5

Carbodenafil is a Sildenafil related compound found in healthy foods. Sildenafil is a PDE5 inhibitor (IC50: 5.22 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 78 In Stock
5MG 64 In Stock
10MG 90 In Stock
25MG 153 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carbodenafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Carbodenafil is a Sildenafil related compound found in healthy foods. Sildenafil is a PDE5 inhibitor (IC50: 5.22 nM).
  • Description
    Carbodenafil is a Sildenafil related compound found in healthy foods. Sildenafil is a PDE5 inhibitor (IC50: 5.22 nM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    944241-52-5
  • Formula Weight
    452.559
  • Molecular Formula
    C24H32N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(ccc1OCC)C(=O)N1CCN(CC)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Antioxidant and anticancer constituents from the leaves of Liriodendron tulipifera.Molecules. 2014 Apr 3;19(4):4234-45.
molnova catalog
related products
  • Roflumilast

    Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor.

  • Enpp-1-IN-14

    ENPP1-IN-2 is a potent inhibitor of Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) with an IC50 value of 32.38 nM for recombinant human ENPP-1. ENPP1-IN-2 has anti-tumor activity.

  • TPN171

    TPN171 is potent PDE5 inhibitor with subnanomolar potency for PDE5 and good selectivity over PDE6, which has the potential for the treatment of pulmonary arterial hypertension (PAH).